Document is current
Any future updates will be listed below
-
Authors
Skinner, Andrew M. https://orcid.org/0000-0001-9452-9316
Lodise, Thomas P.
Reilly, Joseph
Guthmueller, Beth
Srivastava, Shivam
Axelrad, Jordan E.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03931941 at ClinicalTrials.govDocuments that mention this clinical trial
Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome
https://doi.org/10.1007/s40121-025-01208-0
Safety and Efficacy of Fecal Microbiota, Live-jslm for Prevention of Recurrent Clostridioides difficile Infection Among Hospitalized Participants in PUNCH CD3-OLS
https://doi.org/10.1007/s40121-026-01304-9
-
Funding
Funding for this research was provided by:
Ferring Pharmaceuticals
- License Information
-
More Information
Article History
Received: 13 November 2025
Accepted: 14 January 2026
First Online: 7 February 2026
Declarations
:
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Andrew M. Skinner is a consultant for Ferring Pharmaceuticals Inc. and Recursion Pharmaceuticals Inc. Thomas P. Lodise is a consultant for Ferring Pharmaceuticals Inc. Joseph Reilly was a speaker for Ferring Pharmaceuticals Inc. Beth Guthmueller was an employee of Ferring Pharmaceuticals at the time this study was conducted. Shivam Srivastava is an employee of Ferring Pharmaceuticals Inc. Jordan E. Axelrad reports research grants from BioFire Diagnostics, Genentech, Janssen, and Takeda; consultancy fees, honoraria, or advisory board fees from AbbVie, Abviax, Adiso, BioFire Diagnostics, Biomerieux, Bristol Myers Squibb, Celltrion, Eli Lilly, Ferring Pharmaceuticals Inc., Fresenius, Janssen, Johnson & Johnson, Merck, Pfizer, Sanofi, Takeda, and Vedanta.
: All trials were conducted in the USA and Canada according to the ethical principles of the Declaration of Helsinki, Good Clinical Practice guidelines, principles of informed consent, and requirements of publicly registered clinical trials. All participants provided written informed consent, and all protocols received institutional review board/research ethics board approval before study commencement.
